The burgeoning landscape of therapeutic interventions for weight disorders has witnessed considerable attention focused on GLP-3 receptor agonists and, more recently, the dual GIP and GLP-3 receptor agonist https://safagocw201377.wikissl.com/1983961/glp_3_retatrutide_a_comparative_analysis